Runben Biotechnology Statistics
Total Valuation
SHA:603193 has a market cap or net worth of CNY 10.58 billion. The enterprise value is 9.44 billion.
| Market Cap | 10.58B |
| Enterprise Value | 9.44B |
Important Dates
The last earnings date was Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603193 has 404.59 million shares outstanding. The number of shares has decreased by -0.87% in one year.
| Current Share Class | 404.59M |
| Shares Outstanding | 404.59M |
| Shares Change (YoY) | -0.87% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 29.19% |
| Owned by Institutions (%) | 5.64% |
| Float | 79.95M |
Valuation Ratios
The trailing PE ratio is 32.72 and the forward PE ratio is 28.13.
| PE Ratio | 32.72 |
| Forward PE | 28.13 |
| PS Ratio | 6.73 |
| PB Ratio | 4.66 |
| P/TBV Ratio | 4.84 |
| P/FCF Ratio | 60.16 |
| P/OCF Ratio | 36.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.98, with an EV/FCF ratio of 53.68.
| EV / Earnings | 29.24 |
| EV / Sales | 6.01 |
| EV / EBITDA | 25.98 |
| EV / EBIT | 27.67 |
| EV / FCF | 53.68 |
Financial Position
The company has a current ratio of 10.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.98 |
| Quick Ratio | 7.58 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.68% and return on invested capital (ROIC) is 27.41%.
| Return on Equity (ROE) | 14.68% |
| Return on Assets (ROA) | 9.01% |
| Return on Invested Capital (ROIC) | 27.41% |
| Return on Capital Employed (ROCE) | 14.98% |
| Weighted Average Cost of Capital (WACC) | 5.26% |
| Revenue Per Employee | 1.71M |
| Profits Per Employee | 350,640 |
| Employee Count | 921 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 3.51 |
Taxes
In the past 12 months, SHA:603193 has paid 46.12 million in taxes.
| Income Tax | 46.12M |
| Effective Tax Rate | 12.50% |
Stock Price Statistics
The stock price has decreased by -26.33% in the last 52 weeks. The beta is 0.18, so SHA:603193's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -26.33% |
| 50-Day Moving Average | 23.41 |
| 200-Day Moving Average | 26.47 |
| Relative Strength Index (RSI) | 62.36 |
| Average Volume (20 Days) | 7,406,818 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603193 had revenue of CNY 1.57 billion and earned 322.94 million in profits. Earnings per share was 0.80.
| Revenue | 1.57B |
| Gross Profit | 920.17M |
| Operating Income | 341.25M |
| Pretax Income | 369.06M |
| Net Income | 322.94M |
| EBITDA | 362.26M |
| EBIT | 341.25M |
| Earnings Per Share (EPS) | 0.80 |
Balance Sheet
The company has 1.14 billion in cash and 1.06 million in debt, giving a net cash position of 1.14 billion or 2.82 per share.
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 1.06M |
| Net Cash | 1.14B |
| Net Cash Per Share | 2.82 |
| Equity (Book Value) | 2.27B |
| Book Value Per Share | 5.62 |
| Working Capital | 1.54B |
Cash Flow
In the last 12 months, operating cash flow was 291.89 million and capital expenditures -115.97 million, giving a free cash flow of 175.92 million.
| Operating Cash Flow | 291.89M |
| Capital Expenditures | -115.97M |
| Depreciation & Amortization | 21.01M |
| Net Borrowing | n/a |
| Free Cash Flow | 175.92M |
| FCF Per Share | 0.43 |
Margins
Gross margin is 58.54%, with operating and profit margins of 21.71% and 20.55%.
| Gross Margin | 58.54% |
| Operating Margin | 21.71% |
| Pretax Margin | 23.48% |
| Profit Margin | 20.55% |
| EBITDA Margin | 23.05% |
| EBIT Margin | 21.71% |
| FCF Margin | 11.19% |
Dividends & Yields
This stock pays an annual dividend of 0.46, which amounts to a dividend yield of 1.73%.
| Dividend Per Share | 0.46 |
| Dividend Yield | 1.73% |
| Dividend Growth (YoY) | 22.86% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 54.56% |
| Buyback Yield | 0.87% |
| Shareholder Yield | 2.60% |
| Earnings Yield | 3.05% |
| FCF Yield | 1.66% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |